FDA-cleared profile

O-arm O2 Imaging System

Medtronic Navigation, Inc · CBCT · FDA-cleared (510(k))

Authorized purpose: O-arm O2 4.3.0 provides mobile intraoperative two- and three-dimensional X-ray imaging of bony anatomy and metal objects, navigation support, 3D Long Scan, implant artifact reduction, and lower-dose Spine Smart Dose acquisition for labeled patients.

Clinical role
Intraoperative 2D/3D imaging, navigation registration, implant visualization, long-field imaging, and lower-dose spine acquisition.
Images and patients
CBCT · Spine
Key limitation
Keep in mind: The O-arm O2 Imaging System is designed for adult and pediatric patients weighing 60 lbs or greater and having an abdominal thickness greater than 16 cm, and is compatible with certain image guided surgery systems.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: O-arm O2 4.3.0 provides mobile intraoperative two- and three-dimensional X-ray imaging of bony anatomy and metal objects, navigation support, 3D Long Scan, implant artifact reduction, and lower-dose Spine Smart Dose acquisition for labeled patients.
  • Which images or clinical context are in scope?Modality: CBCT Anatomy or clinical context: Spine Input: A mobile x-ray system that provides 3D and 2D imaging.
  • Who uses it?Intended users: Surgeons, spine representatives, and radiation technologists.
  • What does the software produce?Output: 2D or reconstructed 3D images of bony anatomy and metal objects for review and compatible surgical navigation.
  • What is its most important limitation?Key limitation: The O-arm O2 Imaging System is designed for adult and pediatric patients weighing 60 lbs or greater and having an abdominal thickness greater than 16 cm, and is compatible with certain image guided surgery systems.

Clinical takeaway. Clinical role: O-arm O2 4.3.0 provides mobile intraoperative two- and three-dimensional X-ray imaging of bony anatomy and metal objects, navigation support, 3D Long Scan, implant artifact reduction, and lower-dose Spine Smart Dose acquisition for labeled patients.

Evidence takeaway. Evidence from the reviewed source record: K240465 reports blinded review of 100 clinical image pairs, with Spine Smart Dose judged clinically equivalent at roughly one-quarter of corresponding standard-mode dose. Independent comparative research found mode-dependent dose and low-contrast tradeoffs, supporting local protocol testing.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
O-arm O2 4.3.0 provides mobile intraoperative two- and three-dimensional X-ray imaging of bony anatomy and metal objects, navigation support, 3D Long Scan, implant artifact reduction, and lower-dose Spine Smart Dose acquisition for labeled patients.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
Intraoperative 2D/3D imaging, navigation registration, implant visualization, long-field imaging, and lower-dose spine acquisition.
  • Exact FDA submission
  • Checked 2026-09-03
Required input
A mobile x-ray system that provides 3D and 2D imaging.
  • Exact FDA submission
  • Checked 2026-09-19

The exact FDA product description states the mobile x-ray system's 3D and 2D imaging; the current projection-data and mode list is not stated as an input description in the packet.

Output and clinician action
2D or reconstructed 3D images of bony anatomy and metal objects for review and compatible surgical navigation.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Care setting
Operating rooms and surgical imaging environments.
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
Surgeons, spine representatives, and radiation technologists.
  • Exact FDA submission
  • Checked 2026-09-19

The exact FDA usability section identifies these clinically relevant users; it does not establish the dossier's added qualified operating-room-staff wording.

Limitations
The O-arm O2 Imaging System is designed for adult and pediatric patients weighing 60 lbs or greater and having an abdominal thickness greater than 16 cm, and is compatible with certain image guided surgery systems.
  • Exact FDA submission
  • Checked 2026-09-19

The exact FDA indication supplies the patient-size boundary and image-guided-surgery compatibility statement without the dossier's added performance-dependence interpretation.

Evidence summary
K240465 reports blinded review of 100 clinical image pairs, with Spine Smart Dose judged clinically equivalent at roughly one-quarter of corresponding standard-mode dose. Independent comparative research found mode-dependent dose and low-contrast tradeoffs, supporting local protocol testing.
  • Exact FDA submission
  • Checked 2026-09-03

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K240465 reports blinded review of 100 clinical image pairs, with Spine Smart Dose judged clinically equivalent at roughly one-quarter of corresponding standard-mode dose. Independent comparative research found mode-dependent dose and low-contrast tradeoffs, supporting local protocol testing.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.

Spine Smart Dose clinical image pairs

100 pairs

  • EndpointBlinded equivalence review versus predicate modes
  • PopulationO-arm O2 Imaging System
  • Tested versionO-arm O2 Imaging System 4.3.0

Approximate Spine Smart Dose reduction

70 %

  • EndpointPatient-dose reduction described for sparse acquisition
  • PopulationO-arm O2 Imaging System
  • Tested versionO-arm O2 Imaging System 4.3.0

Reviewed SSD dose relative to standard

25 %

  • EndpointApproximate dose of corresponding Standard images
  • PopulationO-arm O2 Imaging System
  • Tested versionO-arm O2 Imaging System 4.3.0

K240465 FDA performance package for O-arm O2 Imaging System

  • DesignManufacturer blinded clinical and cadaver paired-image validation plus phantom, dosimetry, usability, navigation, and bench testing
  • Population100 clinical or cadaver image pairs reviewed by board-certified neuroradiologists plus phantom and simulated-use tests
  • Scopeexact submission
  • Tested versionO-arm O2 Imaging System 4.3.0
  • Samplen=100
  • IndependenceSponsor or vendor study

K240465

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

Radiation exposure and image quality comparison of intraoperative imaging systems

  • DesignIndependent phantom comparison
  • PopulationO-arm O2 and comparator acquisition modes
  • Scopeproduct family
  • Tested versionO-arm O2 product family
  • IndependenceIndependent study

PMID 34111631

Independent technical comparison; protocol and phantom results are not patient outcomes.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
2 reviewed FDA recall records in the 2026-09-02 openFDA snapshot natively identify K240465. Read the model- and version-scoped events and confirm affected-unit and correction status with the manufacturer. FDA recall Z-2101-2025 affects O-arm O2 systems because a gantry-support mechanical component might have been damaged during manufacture. FDA lists the recall as open and classified. FDA recall Z-2451-2026 affects O-arm O2 detector-panel firmware because an anomaly could cause image artifacts. FDA lists the recall as open and classified.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-2101-2025

Open, Classified

2025-07-09

Exact O-arm O2 match. Confirm affected serial number, inspection, and correction status before relying on the system.

recall: Z-2451-2026

Open, Classified

2026-06-15

Exact O-arm O2 model match. Confirm detector firmware and correction status and include artifact recognition in local image-quality controls.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: A mobile x-ray system that provides 3D and 2D imaging.

    Scope: Exact FDA submission. The exact FDA product description states the mobile x-ray system's 3D and 2D imaging; the current projection-data and mode list is not stated as an input description in the packet.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K240465: O-arm O2 Imaging System

  2. Routing

    Source context, not route validation: Image-guided surgery and navigation integration with DICOM or configured image exchange; validate registration accuracy, orientation, geometry, identifiers, and failure recovery.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-03 · FDA K240465: O-arm O2 Imaging System · O-arm surgical imaging system · Radiation exposure and image quality comparison of O-arm O2 and another intraoperative imaging system

  3. AI processing

    Source context, not route validation: Mobile operating-room X-ray/CBCT system with gantry, detector, workstation, navigation interfaces, and radiation-safety controls.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-03 · FDA K240465: O-arm O2 Imaging System · O-arm surgical imaging system · Radiation exposure and image quality comparison of O-arm O2 and another intraoperative imaging system

  4. Returned objects

    Source context, not route validation: 2D or reconstructed 3D images of bony anatomy and metal objects for review and compatible surgical navigation.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K240465: O-arm O2 Imaging System

  5. Viewer/worklist/report

    Unresolved route: 2D or reconstructed 3D images of bony anatomy and metal objects for review and compatible surgical navigation.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K240465: O-arm O2 Imaging System

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Mobile operating-room X-ray/CBCT system with gantry, detector, workstation, navigation interfaces, and radiation-safety controls.
  • Exact FDA submission
  • Checked 2026-09-03
Integration
Image-guided surgery and navigation integration with DICOM or configured image exchange; validate registration accuracy, orientation, geometry, identifiers, and failure recovery.
  • Exact FDA submission
  • Checked 2026-09-03
Training
Only qualified surgeons, radiologic technologists, and trained operating-room staff. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Patient size and age thresholds apply. It is primarily for bony anatomy and metal objects; dose, contrast, field length, artifact reduction, and navigation performance depend on acquisition mode and anatomy.
  • Exact FDA submission
  • Checked 2026-09-03

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K240465 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

Image-guided surgery and navigation integration with DICOM or configured image exchange; validate registration accuracy, orientation, geometry, identifiers, and failure recovery.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Patient size and age thresholds apply. It is primarily for bony anatomy and metal objects; dose, contrast, field length, artifact reduction, and navigation performance depend on acquisition mode and anatomy.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Patient size and age thresholds apply. It is primarily for bony anatomy and metal objects; dose, contrast, field length, artifact reduction, and navigation performance depend on acquisition mode and anatomy.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K240465
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CBCT
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Anatomy
Spine
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-06-21
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
12Source classes checked
3Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 3 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 3 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 2 FDA recall candidates were manually reviewed: 2 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 2 postmarket candidate records; 2 have been reviewed (2 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor product page, peer reviewed publication, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-03 - Exact FDA submission

    Public materials reviewed for this batch do not establish the complete security posture for the exact release. Request data-flow, identity, audit, encryption, retention, support-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

10 sources - 3 history items

Source ledger

  1. FDA K240465: O-arm O2 Imaging System

    U.S. Food and Drug Administration - Published 2024-06-21 - Accessed 2026-09-19

    Scope: purpose, modality, anatomy, output, intendedUsers, input, limitations, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-2101-2025: O-arm O2 Imaging System. Mobile X-Ray System.

    U.S. Food and Drug Administration - Published 2025-07-09 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. FDA recall Z-2451-2026: Medtronic O-arm O2 Imaging System. Model Number: BI70002000.

    U.S. Food and Drug Administration - Published 2026-06-15 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  5. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  6. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  7. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  8. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  9. O-arm surgical imaging system

    Medtronic - Accessed 2026-09-03

    Scope: productFamily, workflowRole, implementationCapabilities, currentCommercialContext

  10. Radiation exposure and image quality comparison of O-arm O2 and another intraoperative imaging system

    European Spine Journal - Accessed 2026-09-03

    Scope: limitations, evidenceSummary, evidenceStudy, evidenceMetrics, monitoring

Research history

  1. K240465 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K231757

Ez3D-i /E3

Ewoosoft Co., Ltd

Authorized purpose: Ez3D-i/E3 provides dental and maxillofacial DICOM viewing, three-dimensional visualization, multiplanar reconstruction, two-dimensional analysis, implant simulation, canal tracing, and bone-density tools for trained radiologists and dentists.

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2023-07-14
FDA-cleared K261289

UNiD™ Spine Analyzer (SW3002)

Medicrea International S.A.S. (Medtronic)

Authorized purpose: UNiD Spine Analyzer SW3002 v5.1.0 enables healthcare professionals to view and measure images and plan orthopedic spine surgeries, including preoperative and postoperative measurements and patient-specific rod or implant planning.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine
Decision
2026-05-15
FDA-cleared K260785

DS Core CBCT Anatomy

Dentsply Sirona

Authorized purpose: DS Core CBCT Anatomy uses CBCT and digital-impression data to provide tooth and jaw segmentation, inferior-alveolar-nerve-canal segmentation, panoramic-curve support, and registration for dental professionals.

Modality
CBCT
Anatomy
Teeth; jaws; and the inferior alveolar nerve canal
Decision
2026-04-23

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history